Recursion Pharmaceuticals, Inc. (RXRX)
4.12
+0.05
(+1.23%)
USD |
NASDAQ |
Oct 02, 16:00
4.12
0.00 (0.00%)
After-Hours: 20:00
Recursion Pharmaceuticals EPS Diluted (Quarterly) : -0.246 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.246 |
| March 31, 2026 | -0.222 |
| December 31, 2025 | -0.2053 |
| September 30, 2025 | -0.363 |
| June 30, 2025 | -0.4119 |
| March 31, 2025 | -0.5027 |
| December 31, 2024 | -0.5324 |
| September 30, 2024 | -0.3392 |
| June 30, 2024 | -0.4027 |
| March 31, 2024 | -0.3871 |
| December 31, 2023 | -0.3988 |
| September 30, 2023 | -0.434 |
| June 30, 2023 | -0.3809 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.3409 |
| December 31, 2022 | -0.3096 |
| September 30, 2022 | -0.3485 |
| June 30, 2022 | -0.3807 |
| March 31, 2022 | -0.3272 |
| December 31, 2021 | -0.3814 |
| September 30, 2021 | -0.2812 |
| June 30, 2021 | -0.2577 |
| March 31, 2021 | -0.1825 |
| December 31, 2020 | -0.1554 |
| September 30, 2020 | -0.1416 |
| June 30, 2020 | -0.1125 |
| March 31, 2020 | -0.1095 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Editas Medicine, Inc. | -0.1528 |
| Amgen, Inc. | 4.366 |
| Halozyme Therapeutics, Inc. | 1.897 |
| Novavax, Inc. | -0.3244 |
| AVITA Medical, Inc. | -0.2492 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -131.00M |
| Revenue (Quarterly) | 7.67M |
| Total Expenses (Quarterly) | 138.68M |
| Enterprise Value | 1.716B |
| Gross Profit Margin (Quarterly) | -202.4% |
| Profit Margin (Quarterly) | -1.71K% |
| Earnings Yield | -25.15% |
| Normalized Earnings Yield | -25.15 |